Alex Azar @SecAzar
.@US_FDA is committed to fostering the development of #biosimilars, which lower drug prices through boosting competition. The agency published new patient-focused educational resources about biosimilars to increase awareness about these treatments: https://t.co/R2ypNuFLuG — PolitiTweet.org